...
首页> 外文期刊>Internal medicine journal >Australians' knowledge and perceptions of direct-to-consumer personal genome testing
【24h】

Australians' knowledge and perceptions of direct-to-consumer personal genome testing

机译:澳大利亚人对消费者直接进行个人基因组检测的知识和看法

获取原文
获取原文并翻译 | 示例
           

摘要

Background: As direct-to-consumer personal genome testing (DTC-PGT) is increasingly available in Australia, knowledge of Australians' perceptions and attitudes towards this technology is needed in order to assess the (potential) impact it might have on the Australian public and healthcare system. Aims: To explore the knowledge and perceptions of DTC-PGT in an Australian sample. Methods: An online survey asking about knowledge and perceptions of DTC-PGT, undertaken between October 2011 and April 2012, of 270 Australian residents. Results were analysed using SAS. Results: Our study found limited consumer knowledge of, and interest in, pursuing DTC-PGT in Australia. Ninety-three per cent of respondents correctly identified DTC-PGT as available to consumers directly, but only 40% correctly identified its availability in Australia. When asked about the content and value of the information DTC-PGT provides, the majority of respondents indentified that DTC-PGT could provide information about one's health and/or ancestry (82% and 74%). Additionally, respondents indicated they believed this information to be equally important as non-genetic information about one's ancestry and health. Conclusion: While a minority of respondents expressed an intention to pursue DTC-PGT (27%), the majority of respondents, irrespective of whether they wished to pursue it or not, believed that genetic information was as important as non-genetic information in regards to their health and their ancestry. The value ascribed to genetic information suggests that genetics plays a role in people's lives, and that further qualitative research could explore the ways in which people might use and understand the genetic information provided by DTC-PGT.
机译:背景:随着在澳大利亚越来越多的直接面向消费者的个人基因组测试(DTC-PGT),需要了解澳大利亚人对该技术的看法和态度,以便评估其对澳大利亚公众的(潜在)影响。和医疗保健系统。目的:探讨澳大利亚样本中DTC-PGT的知识和看法。方法:2011年10月至2012年4月之间,对270名澳大利亚居民进行了在线调查,询问DTC-PGT的知识和看法。使用SAS分析结果。结果:我们的研究发现,在澳大利亚,消费者对DTC-PGT的了解和兴趣有限。 93%的受访者正确地将DTC-PGT识别为可直接用于消费者,但是只有40%的正确识别了其在澳大利亚的可用性。当被问及DTC-PGT提供的信息的内容和价值时,大多数受访者指出DTC-PGT可以提供有关一个人的健康和/或血统的信息(82%和74%)。此外,受访者表示,他们认为这些信息与关于某人血统和健康的非遗传信息同等重要。结论:尽管少数受访者表示有意追求DTC-PGT,但大多数受访者无论是否希望追求DTC-PGT都认为,遗传信息与非遗传信息一样重要。他们的健康和血统。遗传信息的价值表明,遗传在人们的生活中发挥着作用,进一步的定性研究可以探索人们使用和理解DTC-PGT提供的遗传信息的方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号